Post by Margaretta Colangelo

This week in a historic milestone the FDA approved the first ever AI based pathology product for clinical use. Paige Prostate is the first and only AI-based pathology product to receive FDA approval for in vitro diagnostic use in detecting cancer in prostate biopsies. Shout out to Thomas Fuchs, Leo Grady, Jonathan Hirsch, Christopher Kanan Peter Hamilton, PhD, FRCPath (hon) Jeremy Kunz, Thomas Fresneau, SIQI LIU, Juan Antonio Retamero, MD and the whole team at Paige. #artificialintelligence #innovation #healthcare #pathology #cancer Icahn School of Medicine at Mount Sinai